These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

105 related articles for article (PubMed ID: 1285251)

  • 41. Fluorescent location of tumour cells in fine needle aspirates.
    Steven FS; Bell J; Ellis IO
    Anticancer Res; 1991; 11(5):1697-9. PubMed ID: 1768038
    [TBL] [Abstract][Full Text] [Related]  

  • 42. A simple fluorescent technique for the location of tumour cells in frozen sections of the head and neck region.
    Steven FS; Griffin MM; Maier H; Born A; Zoeller J
    Anticancer Res; 1991; 11(3):1189-94. PubMed ID: 1716085
    [TBL] [Abstract][Full Text] [Related]  

  • 43. The fluorescent location of abnormal cervical cells employing the principle of differential competitive inhibition.
    Steven FS; Palcic B
    Anticancer Res; 1994; 14(5A):2017-20. PubMed ID: 7847844
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Evidence for cells possessing t-PA like activity in smears obtained from patients with oral squamous cell carcinoma.
    Steven FS; Griffin MM; Zoeller J; Maier H
    Anticancer Res; 1990; 10(4):995-9. PubMed ID: 2116754
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Inhibitors of guanidinobenzoatase and their possible role in cell migration.
    Steven FS; Griffin MM
    Biol Chem Hoppe Seyler; 1988 May; 369 Suppl():137-43. PubMed ID: 3202961
    [TBL] [Abstract][Full Text] [Related]  

  • 46. The design of fluorescent probes which bind to the active centre of guanidinobenzoatase. Application to the location of cells possessing this enzyme.
    Steven FS; Griffin MM; Al-Ahmad RK
    Eur J Biochem; 1985 May; 149(1):35-40. PubMed ID: 2581779
    [TBL] [Abstract][Full Text] [Related]  

  • 47. The application of double fluorescence to the rapid selection of atypical cervical epithelial cells spread in monolayers.
    Steven FS; Johnson J; Eason P; Tomasic M; Palcic B
    Anticancer Res; 1993; 13(4):1069-73. PubMed ID: 8352527
    [TBL] [Abstract][Full Text] [Related]  

  • 48. The inhibition of a tumour cell surface protease in vivo and its re-activation by oxidation.
    Steven FS; Ali H; Griffin MM
    Br J Cancer; 1988 Feb; 57(2):160-4. PubMed ID: 2451931
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Fluorescent studies directed towards the location of abnormal epithelial cells in cervical smears.
    Steven FS; Johnson J
    Cytopathology; 1990; 1(4):217-22. PubMed ID: 1714306
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Regulation of inhibition of a protease on the surface of human colonic tumour cells.
    Steven FS; Maier H
    Biochem Soc Trans; 1989 Dec; 17(6):1125-6. PubMed ID: 2628108
    [No Abstract]   [Full Text] [Related]  

  • 51. Inhibitors of the cell surface protease guanidinobenzoatase.
    Steven FS; Griffin MM; Maier H; Talbot IC
    Biol Chem Hoppe Seyler; 1990 May; 371 Suppl():89-94. PubMed ID: 2400591
    [No Abstract]   [Full Text] [Related]  

  • 52. Reversible dissociation of a tumor-cell surface protease-inhibitor complex.
    Steven F; Griffin M; Blakey D
    Int J Oncol; 1992 Jun; 1(1):59-61. PubMed ID: 21584510
    [TBL] [Abstract][Full Text] [Related]  

  • 53. The status of trypsin-like enzymes in squamous-cell carcinoma of the head and neck region.
    Steven FS; Williams LA; Maier H; Arndt J; Weidauer H; Born A
    J Cancer Res Clin Oncol; 1990; 116(1):57-64. PubMed ID: 2312606
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Evidence for the induction of protease activity on cultured tumour cells as a consequence of implantation into nude mice.
    Steven FS; Maier H; Arndt J; Born IA
    Cancer Lett; 1990 Apr; 50(3):191-6. PubMed ID: 2182191
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Differential competitive inhibition: the theory of a concept.
    Steven FS
    Anticancer Res; 1994; 14(5A):2011-2. PubMed ID: 7847842
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Labelling of tumour cells with a biotinylated inhibitor of a cell surface protease.
    Steven FS; Griffin MM; Williams LA; Clarke NW; Maier H
    J Enzyme Inhib; 1991; 4(4):337-46. PubMed ID: 1669833
    [TBL] [Abstract][Full Text] [Related]  

  • 57. A fluorescent study of ligands for guanidinobenzoatase, a protease associated with tumour cells.
    Steven F; Griffin MM; Williams LA; Feichter G
    Anticancer Res; 1988; 8(6):1179-83. PubMed ID: 3218954
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Further inhibition studies on guanidinobenzoatase, a trypsin-like enzyme associated with tumour cells.
    Steven FS; Griffin MM; Wong TL; Yasmin R; Mangel WF
    J Enzyme Inhib; 1987; 1(3):187-201. PubMed ID: 3334244
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Fluorescent location of abnormal cells in cell smears obtained from the lungs of patients with lung cancer.
    Steven FS; Lam S; Macaulay C; Palcic B
    Anticancer Res; 1992; 12(3):625-9. PubMed ID: 1622117
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Interactions of proteases, protease inhibitors, and the beta1 integrin/laminin gamma3 protein complex in the regulation of ectoplasmic specialization dynamics in the rat testis.
    Siu MK; Cheng CY
    Biol Reprod; 2004 Apr; 70(4):945-64. PubMed ID: 14645107
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.